The sixth report of the Joint National Committee on prevention, detection, evaluation, and treatment of high blood pressure.

Racial and ethnic minority populations are growing segments of our society. The prevalence of hypertension in these populations differs across groups, and control rates are not as good as in the general population. Clinicians should be aware of these management challenges, taking social and cultural factors into account. Guidelines are provided for management of children and women with hypertension. In older persons, diuretics are preferred and long-acting dihydropyridine calcium antagonists may be considered. Specific therapy for patients with LVH, coronary artery disease, and heart failure are outlined. Patients with renal insufficiency with greater than 1 g/d of proteinuria should be treated to a therapy blood pressure goal of 125/75 mm Hg; those with less proteinuria should be treated to a blood pressure goal of 130/85 mm Hg. ACE inhibitors have additional renoprotective effects over other antihypertensive agents. Patients with diabetes should be treated to a therapy blood pressure goal of below 130/85 mm Hg. Hypertension may coexist with various other conditions and may be induced by various pressor agents.

[1]  D. S. Fleming,et al.  Hypertension control. , 1975, Minnesota medicine.

[2]  David H. Gustafson,et al.  Group Techniques for Program Planning: A Guide to Nominal Group and Delphi Processes , 1976 .

[3]  B. Garrett,et al.  Moderate sodium restriction and various diuretics in the treatment of hypertension. , 1981, Archives of internal medicine.

[4]  R P Russell,et al.  Five-year blood pressure control and mortality following health education for hypertensive patients. , 1983, American journal of public health.

[5]  S. Blair,et al.  Physical fitness and incidence of hypertension in healthy normotensive men and women. , 1984, JAMA.

[6]  R. Peto,et al.  Beta blockade during and after myocardial infarction: an overview of the randomized trials. , 1985, Progress in cardiovascular diseases.

[7]  J. Kotchen,et al.  Impact of a rural high blood pressure control program on hypertension control and cardiovascular disease mortality. , 1986, JAMA.

[8]  T S Warrender,et al.  Randomised trial of treatment of hypertension in elderly patients in primary care. , 1986, British medical journal.

[9]  N. Shulman,et al.  Adverse effects of antihypertensive medications in the Hypertension Detection and Follow-up Program. , 1986, Progress in cardiovascular diseases.

[10]  F. Messerli Osler's maneuver, pseudohypertension, and true hypertension in the elderly. , 1986, American Journal of Medicine.

[11]  M. Blaufox,et al.  Is thiazide-produced uric acid elevation harmful? Analysis of data from the Hypertension Detection and Follow-up Program. , 1987, Archives of internal medicine.

[12]  F. Tristani,et al.  Effect of Vasodilator Therapy on Mortality in Chronic Congestive Heart Failure. Results of a Veterans Administration Cooperative Study , 1987 .

[13]  S. Thompson,et al.  The relationship between smoking and the response to anti-hypertensive treatment in mild hypertensives in the Medical Research Council's trial of treatment. , 1987, International journal of epidemiology.

[14]  M. Pagala,et al.  Rhabdomyolysis related to cocaine abuse. , 1988, Annals of internal medicine.

[15]  M. Kryger,et al.  Mortality and apnea index in obstructive sleep apnea. Experience in 385 male patients. , 1988, Chest.

[16]  W. L. Ooi,et al.  Impact of Race on Treatment Response and Cardiovascular Disease Among Hypertensives , 1989, Hypertension.

[17]  A. Dyer,et al.  Primary prevention of hypertension by nutritional-hygienic means. Final report of a randomized, controlled trial. , 1989, JAMA.

[18]  R. Juster,et al.  Prognostic value of ambulatory blood pressure measurements: further analyses. , 1989, Journal of hypertension. Supplement : official journal of the International Society of Hypertension.

[19]  C. Bulpitt,et al.  Relation between mortality and treated blood pressure in elderly patients with hypertension: report of the European Working Party on High Blood Pressure in the Elderly. , 1989, BMJ.

[20]  E. McCarthy,et al.  Combined α/β‐blockade versus β1‐selective blockade in essential hypertension in black and white patients , 1990 .

[21]  L. Goldman,et al.  Long-term cost-effectiveness of various initial monotherapies for mild to moderate hypertension. , 1990, JAMA.

[22]  R. Ward Familial aggregation and genetic epidemiology of blood pressure , 1990 .

[23]  L. Hillis,et al.  Potentiation of cocaine-induced coronary vasoconstriction by beta-adrenergic blockade. , 1990, Annals of internal medicine.

[24]  E. O’Brien,et al.  The British Hypertension Society protocol for the evaluation of automated and semi-automated blood pressure measuring devices with special reference to ambulatory systems. , 1990, Journal of hypertension.

[25]  A. J. Dunning,et al.  Relaxation therapy and continuous ambulatory blood pressure in mild hypertension: a controlled study. , 1990, BMJ.

[26]  D. Hillman,et al.  Association of sleep apnoea with myocardial infarction in men , 1990, The Lancet.

[27]  C. Lieber,et al.  High blood alcohol levels in women. The role of decreased gastric alcohol dehydrogenase activity and first-pass metabolism. , 1990, The New England journal of medicine.

[28]  K. Anderson,et al.  An updated coronary risk profile. A statement for health professionals. , 1991, Circulation.

[29]  C. Mulrow,et al.  The J-curve phenomenon and the treatment of hypertension. Is there a point beyond which pressure reduction is dangerous? , 1991, JAMA.

[30]  J. Laragh,et al.  Relation of left ventricular mass and geometry to morbidity and mortality in uncomplicated essential hypertension. , 1991, Annals of internal medicine.

[31]  J. Stamler Blood pressure and high blood pressure. Aspects of risk. , 1991, Hypertension.

[32]  Edward M. Hitchcock,et al.  Alcohol consumption--a risk factor for hemorrhagic and non-hemorrhagic stroke. , 1991, The American journal of medicine.

[33]  Salim Yusuf,et al.  Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure. , 1991, The New England journal of medicine.

[34]  T. Sos Angioplasty for the Treatment of Azotemia and Renovascular Hypertension in Atherosclerotic Renal Artery Disease , 1991, Circulation.

[35]  J. Lalouel,et al.  A chimaeric llβ-hydroxylase/aldosterone synthase gene causes glucocorticoid-remediable aldosteronism and human hypertension , 1992, Nature.

[36]  R. Portman,et al.  Hypertension during reduction of long-term steroid therapy in young subjects with asthma. , 1992, The Journal of allergy and clinical immunology.

[37]  G. Striker Modification of diet in renal disease. , 1992, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[38]  E. J. Brown,et al.  Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction. Results of the survival and ventricular enlargement trial. The SAVE Investigators. , 1992, The New England journal of medicine.

[39]  L. Hansson,et al.  Morbidity and mortality in the Swedish trial in old patients with hypertension (STOP-hypertension). Commentary , 1992 .

[40]  H. Black,et al.  Refractory hypertension. , 1992, The New England journal of medicine.

[41]  A S Berson,et al.  National Standard for Measurement of Resting and Ambulatory Blood Pressures With Automated Sphygmomanometers , 1993, Hypertension.

[42]  L. Kuller,et al.  Morbidity and mortality in hypertensive adults with a low ankle/arm blood pressure index. , 1993, JAMA.

[43]  D. Levy,et al.  The natural history of borderline isolated systolic hypertension. , 1993, The New England journal of medicine.

[44]  R. Bain,et al.  The effect of angiotensin-converting-enzyme inhibition on diabetic nephropathy. , 1993 .

[45]  L. Appel,et al.  Ambulatory Blood Pressure Monitoring and Blood Pressure Self-Measurement in the Diagnosis and Management of Hypertension , 1993, Annals of Internal Medicine.

[46]  C. Lewis,et al.  Treatment of Mild Hypertension Study: Final Results , 1993 .

[47]  B. Kasiske,et al.  Effect of Antihypertensive Therapy on the Kidney in Patients with Diabetes: A Meta-Regression Analysis , 1993, Annals of Internal Medicine.

[48]  A. Rodgers,et al.  The effects of blood pressure reduction in older patients: an overview of five randomized controlled trials in elderly hypertensives. , 1993, Clinical and experimental hypertension.

[49]  D J Reda,et al.  Single-Drug Therapy for Hypertension in Men -- A Comparison of Six Antihypertensive Agents with Placebo , 1993 .

[50]  B. Morgenstern,et al.  Human blood pressure determination by sphygmomanometry. , 1993, Circulation.

[51]  T. Riles,et al.  Plasma catecholamine concentrations during abdominal aortic aneurysm surgery: The link to perioperative myocardial ischemia , 1993, Annals of vascular surgery.

[52]  D. Levy,et al.  A multifactorial approach to coronary disease risk assessment. , 1993, Clinical and experimental hypertension.

[53]  R S Paffenbarger,et al.  The association of changes in physical-activity level and other lifestyle characteristics with mortality among men. , 1993, The New England journal of medicine.

[54]  A Tremblay,et al.  Waist circumference and abdominal sagittal diameter: best simple anthropometric indexes of abdominal visceral adipose tissue accumulation and related cardiovascular risk in men and women. , 1994, The American journal of cardiology.

[55]  K. Koury,et al.  A Multifactorial Trial Design to Assess Combination Therapy in Hypertension: Treatment With Bisoprolol and Hydrochlorothiazide , 1994 .

[56]  G. Reboldi,et al.  Ambulatory blood pressure. An independent predictor of prognosis in essential hypertension. , 1994, Hypertension.

[57]  W. L. Ooi,et al.  Relation of pulse pressure and blood pressure reduction to the incidence of myocardial infarction. , 1994, Hypertension.

[58]  M. Cirillo,et al.  Urinary sodium to potassium ratio and urinary stone disease. The Gubbio Population Study Research Group. , 1994, Kidney international.

[59]  E. Lander,et al.  Genetic dissection of complex traits science , 1994 .

[60]  L. Lind,et al.  Long-term metabolic effects of antihypertensive drugs. , 1994, American heart journal.

[61]  R. Collins,et al.  Blood pressure, antihypertensive drug treatment and the risks of stroke and of coronary heart disease. , 1994, British medical bulletin.

[62]  Jönsson Bg Cost-benefit of treating hypertension. , 1994 .

[63]  S. Sheps,et al.  Management of patients with hypertension: a hypertension clinic model. , 1994, Mayo Clinic proceedings.

[64]  D. Levy,et al.  Prognostic implications of baseline electrocardiographic features and their serial changes in subjects with left ventricular hypertrophy. , 1994, Circulation.

[65]  R. Klein,et al.  Hypertension and retinopathy, arteriolar narrowing, and arteriovenous nicking in a population. , 1994, Archives of ophthalmology.

[66]  P Whelton,et al.  Prevalence of hypertension in the US adult population. Results from the Third National Health and Nutrition Examination Survey, 1988-1991. , 1995, Hypertension.

[67]  J. Miller,et al.  Early predictors of 15-year end-stage renal disease in hypertensive patients. , 1995, Hypertension.

[68]  K. Bønaa,et al.  Effects of n-3 polyunsaturated fatty acids on glucose homeostasis and blood pressure in essential hypertension. A randomized, controlled trial. , 1995, Annals of Internal Medicine.

[69]  F P Cappuccio,et al.  Epidemiologic association between dietary calcium intake and blood pressure: a meta-analysis of published data. , 1995, American journal of epidemiology.

[70]  S. Yusuf,et al.  Overview of randomized trials of angiotensin-converting enzyme inhibitors on mortality and morbidity in patients with heart failure. Collaborative Group on ACE Inhibitor Trials. , 1995, JAMA.

[71]  J. Laragh,et al.  Low urinary sodium is associated with greater risk of myocardial infarction among treated hypertensive men. , 1995, Hypertension.

[72]  F. Cappuccio,et al.  Reduction of salt intake during converting enzyme inhibitor treatment compared with addition of a thiazide. , 1995, Hypertension.

[73]  T. Raghunathan,et al.  The risk of myocardial infarction associated with antihypertensive drug therapies. , 1995, JAMA.

[74]  R. Glynn,et al.  Use of antihypertensive drugs and trends in blood pressure in the elderly. , 1995, Archives of internal medicine.

[75]  D. Reda,et al.  Response to a Second Single Antihypertensive Agent Used as Monotherapy for Hypertension After Failure of the Initial Drug , 1995 .

[76]  B. Kasiske,et al.  Effects of Antihypertensive Therapy on Serum Lipids , 1995, Annals of Internal Medicine.

[77]  B. Psaty,et al.  Nifedipine. Dose-related increase in mortality in patients with coronary heart disease. , 1995, Circulation.

[78]  L. Ramsay,et al.  Treatment of hypertension in the elderly , 1995, Journal of hypertension.

[79]  K. Kochanek,et al.  Advance report of final mortality statistics, 1991 , 1995 .

[80]  D. Kerr,et al.  A longitudinal study of the effect of sodium and calcium intakes on regional bone density in postmenopausal women. , 1995, The American journal of clinical nutrition.

[81]  L. Bang,et al.  24-h ambulatory blood pressure in 352 normal Danish subjects, related to age and gender. , 1995, American journal of hypertension.

[82]  K. Hansen,et al.  Renovascular disease in older patients beginning renal replacement therapy. , 1995, Kidney international.

[83]  R. Prineas,et al.  Comparison of five antihypertensive monotherapies and placebo for change in left ventricular mass in patients receiving nutritional-hygienic therapy in the Treatment of Mild Hypertension Study (TOMHS). , 1995, Circulation.

[84]  Daniel L. McGee,et al.  The relative effects of left ventricular hypertrophy, coronary artery disease, and ventricular dysfunction on survival among black adults. , 1995, JAMA.

[85]  D. Reda,et al.  Effects of regular exercise on blood pressure and left ventricular hypertrophy in African-American men with severe hypertension. , 1995, The New England journal of medicine.

[86]  P Whelton,et al.  Trends in the prevalence, awareness, treatment, and control of hypertension in the adult US population. Data from the health examination surveys, 1960 to 1991. , 1995, Hypertension.

[87]  Is blood pressure treatment as effective in a population setting as in controlled trials? Results from a prospective study. , 1995, Journal of hypertension.

[88]  J. Hollander The management of cocaine-associated myocardial ischemia. , 1995, The New England journal of medicine.

[89]  S. Sheps,et al.  American National Standard for nonautomated sphygmomanometers. Summary report. , 1995, American journal of hypertension.

[90]  G. Guyatt,et al.  Users' Guides to the Medical Literature: IX. A Method for Grading Health Care Recommendations , 1995 .

[91]  A Shamiss,et al.  Altered circadian rhythm of blood pressure in shift workers. , 1995, Journal of human hypertension.

[92]  G. Bakris,et al.  Newer approaches to antihypertensive therapy. Use of fixed-dose combination therapy. , 1996, Archives of internal medicine.

[93]  N. Polissar,et al.  A prospective study of disease progression in patients with atherosclerotic renal artery stenosis. , 1995, American journal of hypertension.

[94]  A. Wallace,et al.  Effect of atenolol on mortality and cardiovascular morbidity after noncardiac surgery. Multicenter Study of Perioperative Ischemia Research Group. , 1996, The New England journal of medicine.

[95]  P. Elliott,et al.  Dietary calcium and blood pressure: a meta-analysis of randomized clinical trials. , 1996, Annals of internal medicine.

[96]  M. Alderman,et al.  The association between birthplace and mortality from cardiovascular causes among black and white residents of New York City. , 1996, The New England journal of medicine.

[97]  M. Lishner,et al.  Long-term renoprotective effect of angiotensin-converting enzyme inhibition in non-insulin-dependent diabetes mellitus. A 7-year follow-up study. , 1996, Archives of internal medicine.

[98]  G. Reaven,et al.  Hypertension and associated metabolic abnormalities--the role of insulin resistance and the sympathoadrenal system. , 1996, The New England journal of medicine.

[99]  P. Fioretto,et al.  Effects of Cilazapril and Amlodipine on Kidney Function in Hypertensive NIDDM Patients , 1996, Diabetes.

[100]  S. Yusuf,et al.  Coronary heart disease and its risk factors in first-generation immigrant Asian Indians to the United States of America. , 1996, Indian Heart Journal.

[101]  R. Vasan,et al.  The progression from hypertension to congestive heart failure. , 1996, JAMA.

[102]  R. Vasan,et al.  The role of hypertension in the pathogenesis of heart failure. A clinical mechanistic overview. , 1996, Archives of internal medicine.

[103]  Putting it all together: summary of the NHLBI Workshop on the Epidemiology of Hypertension in Hispanic American, Native American, and Asian/Pacific Islander American Populations. , 1996, Public health reports.

[104]  C. Lewis,et al.  Long-term effects on plasma lipids of diet and drugs to treat hypertension , 1996 .

[105]  S. Goldman Renal artery angioplasty: technical results and clinical outcome in 320 patients. , 1996, The Journal of urology.

[106]  W M O'Fallon,et al.  Stroke incidence, prevalence, and survival: secular trends in Rochester, Minnesota, through 1989. , 1996, Stroke.

[107]  Dietary protein and blood pressure. , 1996, JAMA.

[108]  B. Howard,et al.  Hypertension in adult American Indians. The Strong Heart Study. , 1996, Hypertension.

[109]  F. Locatelli,et al.  Effect of the Angiotensin-Converting–Enzyme Inhibitor Benazepril on the Progression of Chronic Renal Insufficiency , 1996 .

[110]  Richard P. Lewis,et al.  ACC/AHA guidelines for the management of patients with acute myocardial infarction. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Management of Acute Myocardial Infarction). , 1996, Journal of the American College of Cardiology.

[111]  M. Moser,et al.  Prevention of disease progression, left ventricular hypertrophy and congestive heart failure in hypertension treatment trials. , 1996, Journal of the American College of Cardiology.

[112]  B. Egan,et al.  Trial of stress reduction for hypertension in older African Americans. II. Sex and risk subgroup analysis. , 1996, Hypertension.

[113]  P. Kowey,et al.  Should a moratorium be placed on sublingual nifedipine capsules given for hypertensive emergencies and pseudoemergencies? , 1996, JAMA.

[114]  T. Kotchen Attenuation of hypertension by insulin-sensitizing agents. , 1996, Hypertension.

[115]  P. Elliott,et al.  Intersalt revisited: further analyses of 24 hour sodium excretion and blood pressure within and across populations , 1996 .

[116]  R. Gibbons,et al.  Guidelines for perioperative cardiovascular evaluation for noncardiac surgery. Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Perioperative Cardiovascular Evaluation for Noncardiac Surgery). , 1996, Journal of the American College of Cardiology.

[117]  C. Albert,et al.  Adjunctive drug therapy of acute myocardial infarction--evidence from clinical trials. , 1996, The New England journal of medicine.

[118]  D. Phillips,et al.  Accuracy of automated finger blood pressure devices. , 1996, Family medicine.

[119]  R. Preston,et al.  Renal Parenchymal Hypertension: current concepts of pathogenesis and management. , 1996, Archives of internal medicine.

[120]  J. Cohn,et al.  The effect of carvedilol on morbidity and mortality in patients with chronic heart failure. U.S. Carvedilol Heart Failure Study Group. , 1996, The New England journal of medicine.

[121]  Alan C. Wilson,et al.  Serum lipids and incidence of coronary heart disease. Findings from the Systolic Hypertension in the Elderly Program (SHEP). , 1996, Circulation.

[122]  A. Logan,et al.  Effect of reduced dietary sodium on blood pressure: a meta-analysis of randomized controlled trials. , 1996, JAMA.

[123]  Jennifer S. Lin,et al.  Sociodemographic influences on Hispanic-white differences in blood pressure. , 1996, Public health reports.

[124]  Pre-eclampsia-eclampsia 1996: preventable? Have disputes on its treatment been resolved? , 1996, Current opinion in nephrology and hypertension.

[125]  M. Weinberger,et al.  Salt sensitivity of blood pressure in humans. , 1996, Hypertension.

[126]  M. Hill,et al.  Enhancing the role of community-health workers in research. , 1996, Image--the journal of nursing scholarship.

[127]  W. Boden,et al.  Calcium channel antagonists: Fried or Foe in postinfarction patients? , 1996 .

[128]  C M O'Connor,et al.  Effect of amlodipine on morbidity and mortality in severe chronic heart failure. Prospective Randomized Amlodipine Survival Evaluation Study Group. , 1996, The New England journal of medicine.

[129]  J. Guralnik,et al.  Risk of gastrointestinal haemorrhage with calcium antagonists in hypertensive persons over 67 years old , 1996, The Lancet.

[130]  G. MacGregor,et al.  Salt—more adverse effects , 1996, The Lancet.

[131]  B. Sibai Treatment of hypertension in pregnant women. , 1996, The New England journal of medicine.

[132]  F. Gueyffier,et al.  New meta-analysis of treatment trials of hypertension: improving the estimate of therapeutic benefit. , 1996, Journal of human hypertension.

[133]  B. Davis,et al.  Effect of diuretic-based antihypertensive treatment on cardiovascular disease risk in older diabetic patients with isolated systolic hypertension. Systolic Hypertension in the Elderly Program Cooperative Research Group. , 1996, JAMA.

[134]  S. Leurgans,et al.  Calcium channel blockers versus other antihypertensive therapies on progression of NIDDM associated nephropathy. , 1996, Kidney international.

[135]  B. Davis,et al.  The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events Trial investigators. , 1996, The New England journal of medicine.

[136]  P. Whelton,et al.  Blood pressure and end-stage renal disease in men. , 1996, The New England journal of medicine.

[137]  P. Okin,et al.  Regression of left ventricular hypertrophy as a surrogate end-point for morbid events in hypertension treatment trials , 1996, Journal of hypertension. Supplement : official journal of the International Society of Hypertension.

[138]  W. Kannel Blood pressure as a cardiovascular risk factor: prevention and treatment. , 1996, JAMA.

[139]  Choice of initial therapy for hypertension. , 1996, JAMA.

[140]  J. Cutler,et al.  Randomized trials of sodium reduction: an overview. , 1997, The American journal of clinical nutrition.

[141]  Strategies for antihypertensive treatment decisions: how to assess benefits? , 1997, Journal of hypertension.

[142]  Y Wang,et al.  Readmission after hospitalization for congestive heart failure among Medicare beneficiaries. , 1997, Archives of internal medicine.

[143]  L. Hansson,et al.  Underestimation of the true benefits of antihypertensive treatment: an assessment of some important sources of error. , 1997, Journal of hypertension.

[144]  B. Psaty,et al.  Clinical implications of the World Health Organization-International Society of Hypertension statement on calcium antagonists. , 1997, Journal of hypertension.

[145]  Xianglin L. Du,et al.  Case-control study of stroke and the quality of hypertension control in north west England , 1997, BMJ.

[146]  Bertram Pitt,et al.  Randomised trial of losartan versus captopril in patients over 65 with heart failure (Evaluation of Losartan in the Elderly Study, ELITE) , 1997, The Lancet.

[147]  E. Roccella,et al.  Hypertension-related morbidity and mortality in the southeastern United States. , 1997, The American journal of the medical sciences.

[148]  R. Devereux,et al.  Do antihypertensive drugs differ in their ability to regress left ventricular hypertrophy? , 1997, Circulation.

[149]  P. Whelton,et al.  End-stage renal disease in African-American and white men. 16-year MRFIT findings. , 1997, JAMA.

[150]  D. Reda,et al.  Effect of single-drug therapy on reduction of left ventricular mass in mild to moderate hypertension: comparison of six antihypertensive agents. The Department of Veterans Affairs Cooperative Study Group on Antihypertensive Agents. , 1997, Circulation.

[151]  Roberto Sega,et al.  Blood-pressure control in the hypertensive population , 1997, The Lancet.

[152]  A. Stewart,et al.  Relationships of quality-of-life measures to long-term lifestyle and drug treatment in the Treatment of Mild Hypertension Study. , 1997, Archives of internal medicine.

[153]  A. Caggiula,et al.  Relation of changes in dietary lipids and weight, trial years 1-6, to changes in blood lipids in the special intervention and usual care groups in the Multiple Risk Factor Intervention Trial. , 1997, The American journal of clinical nutrition.

[154]  T. Ohkubo,et al.  Proposal of reference values for home blood pressure measurement: prognostic criteria based on a prospective observation of the general population in Ohasama, Japan. , 1997, American journal of hypertension.

[155]  J. Ménard,et al.  The absolute risk as a guide to influence the treatment decision-making process in mild hypertension. , 1997, Journal of hypertension.

[156]  D. Vidt,et al.  Cholesterol emboli: a common cause of renal failure. , 1997, Annual review of medicine.

[157]  J. Stamler,et al.  Relation of smoking at baseline and during trial years 1-6 to food and nutrient intakes and weight in the special intervention and usual care groups in the Multiple Risk Factor Intervention Trial. , 1997, The American journal of clinical nutrition.

[158]  S. Sheps,et al.  Limited echocardiography for hypertensive left ventricular hypertrophy. , 1997, Hypertension.

[159]  K. Manton,et al.  Chronic disability trends in elderly United States populations: 1982-1994. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[160]  A. Caggiula,et al.  Relation of body mass and alcohol, nutrient, fiber, and caffeine intakes to blood pressure in the special intervention and usual care groups in the Multiple Risk Factor Intervention Trial. , 1997, The American journal of clinical nutrition.

[161]  Cyclosporine, Blood Pressure and Atherosclerosis , 1997 .

[162]  J. Robbins,et al.  Combined enalapril and felodipine extended release (ER) for systemic hypertension. Enalapril-Felodipine ER Factorial Study Group. , 1997, The American journal of cardiology.

[163]  B. Davis,et al.  Prevention of Heart Failure by Antihypertensive Drug Treatment in Older Persons With Isolated Systolic Hypertension , 1997 .

[164]  Glen D Georger Patterns of orthostatic blood pressure change and their clinical correlates in a frail, elderly population , 1997 .

[165]  G. Bakris,et al.  Effect of calcium channel or beta-blockade on the progression of diabetic nephropathy in African Americans. , 1997, Hypertension.

[166]  R. Schmieder,et al.  Salt. A perpetrator of hypertensive target organ disease? , 1997, Archives of internal medicine.

[167]  J. Cutler,et al.  Effect of Antihypertensive Drug Treatment on Cardiovascular Outcomes in Women and Men , 1997, Annals of Internal Medicine.

[168]  M. Pahor,et al.  Use of calcium antagonists and need for perioperative transfusion in older patients with hip fracture: observational study , 1997, BMJ.

[169]  M. Hill,et al.  The multilevel compliance challenge: recommendations for a call to action. A statement for healthcare professionals. , 1997, Circulation.

[170]  K. Mclaughlin Effect of renal-artery stenting on progression of renovascular renal failure , 1997, The Lancet.

[171]  A. Levey,et al.  Achievement and safety of a low blood pressure goal in chronic renal disease. The Modification of Diet in Renal Disease Study Group. , 1997, Hypertension.

[172]  W. Edwards,et al.  Valvular heart disease associated with fenfluramine-phentermine. , 1997, The New England journal of medicine.

[173]  M. Alderman,et al.  Effect of long-acting and short-acting calcium antagonists on cardiovascular outcomes in hypertensive patients , 1997, The Lancet.

[174]  C. Hennekens,et al.  Cholesterol lowering with statin drugs, risk of stroke, and total mortality. An overview of randomized trials. , 1997, JAMA.

[175]  S. Textor Renal failure related to angiotensin-converting enzyme inhibitors. , 1997, Seminars in nephrology.

[176]  B. Psaty,et al.  Health Outcomes Associated with Antihypertensive Therapies Used as First-Line Agents: A Systematic Review and Meta-analysis , 1998 .

[177]  W. Ray,et al.  Antihypertensives and the Risk of Serious Hypoglycemia in Older Persons Using Insulin or Sulfonylureas , 1998 .

[178]  P. Whelton,et al.  Effects of Oral Potassium on Blood Pressure: Meta-Analysis of Randomized Controlled Clinical Trials , 1998 .